• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:徐兵勇,潘迎锋,平丽.左乙拉西坦缓释片的制备及其Beagle犬体内药动学研究[J].中国现代应用药学,2017,34(9):1266-1271.
XU Bingyong,PAN Yingfeng,PING Li.Study on Preparation of Levetiracetam Sodium Extended-release Tablet and It's Pharmacokinetics in Beagle Dogs[J].Chin J Mod Appl Pharm(中国现代应用药学),2017,34(9):1266-1271.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2265次   下载 2005 本文二维码信息
码上扫一扫!
分享到: 微信 更多
左乙拉西坦缓释片的制备及其Beagle犬体内药动学研究
徐兵勇1,2, 潘迎锋1, 平丽3
1.浙江省药品化妆品审评中心, 杭州 310012;2.正大青春宝药业有限公司, 杭州 310012;3.浙江大学药物安全评价研究中心, 杭州 310058
摘要:
目的 制备左乙拉西坦缓释片,进行体外释放特性以及Beagle犬体内药动学研究。方法 按照筛选处方制备左乙拉西坦缓释片,以市售左乙拉西坦缓释片(Keppra-XR)为参比制剂,采用相似因子(f2)法进行体外释放行为相似度评价;并将自制左乙拉西坦缓释片与市售普通片进行Beagle犬体内药动学参数比较。结果 自制左乙拉西坦缓释片与市售左乙拉西坦缓释片体外释放行为相似。市售左乙拉西坦普通片和自制左乙拉西坦缓释片的药动学参数Tmax分别为(1.75±0.50)和(5.50±1.00)h,Cmax分别为(30.33±2.00)和(17.29±3.56)mg·L-1,AUC0-t分别为(186.88±8.83)和(202.50±34.20)mg·L-1·h。结论 自制的左乙拉西坦缓释片具有缓释效果。
关键词:  左乙拉西坦  缓释片  药动学
DOI:10.13748/j.cnki.issn1007-7693.2017.09.011
分类号:R943;R969.1
基金项目:
Study on Preparation of Levetiracetam Sodium Extended-release Tablet and It's Pharmacokinetics in Beagle Dogs
XU Bingyong1,2, PAN Yingfeng1, PING Li3
1.Zhejiang Center for Drug and Cosmetics Evaluation, Hangzhou 310012, China;2.Chiatai Qingchunbao Pharmaceutical Co., Ltd., Hangzhou 310012, China;3.Center for Drug Safety Evaluation, Zhejiang University, Hangzhou 310058, China
Abstract:
OBJECTIVE To prepare the Levetiracetam extended-release tablet and investigate its pharmacokinetics in Beagle dogs and in vitro release. METHODS Prearation of Levetiracetam extended-release tablet according to optimized prescription, choosed sell products(Keppra-XR) as reference products, evaluation of in vitro release behavior similarity by the similar factor(f2). The pharmacokinetic parameters were compared between the self-made extended-release tablet and the sell tablet. RESULTS The self-made extended-release tablet was similar to the reference products in vitro release, Tmax of reference products and self-made extended-release tablet were (1.75±0.50) and (5.50±1.00) h, Cmax were (30.33±2.00) and (17.29±3.56) mg·L-1, AUC0-t were (186.88±8.83) and (202.50±34.20) mg·L-1·h. CONCLUSION The self-made Levetiracetam extended-release tablet exhibits the sustained release characteristics in vitro.
Key words:  Levetiracetam  extended-release tablet  pharmacokinetics
扫一扫关注本刊微信